Perspective Therapeutics (CATX) said Wednesday it has started shipping its investigational radiopharmaceutical therapies from a recently acquired manufacturing facility in Somerset, New Jersey.
The company said it expects the facility to meet future clinical trial and commercial demands at major cancer treatment centers throughout the northeastern US.
Shares of Perspective Therapeutics were up nearly 3% in recent trading.
Price: 12.90, Change: +0.33, Percent Change: +2.67
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.